2023
Burgoine T, Austin D, Wu J, Quinn T, Surmer P, Gale CP, Wilkinson C. Automated external defibrillator location and socioeconomic deprivation in Great Britain. Heart Published Online First: 28 August 2023. doi: 10.1136/heartjnl-2023-322985
Loh S, Ekinci Y, Spray L, Jeyalan V, Olin T, Richardson G, Austin D, Alkhalil M, Spyridopoulos I. Fractalkine Signalling (CX3CL1/CX3CR1 Axis) as an Emerging Target in Coronary Artery Disease. Journal of Clinical Medicine. 2023; 12(14):4821. https://doi.org/10.3390/jcm12144821
Bawamia B, Spray L, Wangsaputra V, Bennaceur K, Vahabi S, Stellos K, Kharatikoopaei E, Ogundimu E, Gale C, Keavney B, Maier R, Hancock H, Richardson G, Austin D, Spyridopoulos I. Activation of telomerase by TA-65 enhances immunity and reduces inflammation post myocardial infarction, GeroScience, Apr 2023, PMID: 37086366
2022 and 2021
Maier R, Plummer C, Kasim A, Akhter N, Ogundimu E, Maddox J, Graham J, Stewart M, Wardley A, Haney S, Vahabi S, Oxenham H, Humpfreys A, Cresti N, Verrill M, Graham R, Chang L, Hancock H, Austin D, Preventing cardiotoxicity in patients with breast cancer and lymphoma: protocol for a multicentre randomised controlled trial (PROACT), BMJ Open, 2022;12:e066252. doi: 10.1136/bmjopen-2022-066252
Razvi S, Jabbar A, Bano A, Ingoe L, Carey P, Junejo S, Thomas H, Addison C, Austin D, Greenwood J, and Zaman A. Triiodothyronine (T3), inflammation and mortality risk in patients with acute myocardial infarction, European Thyroid Journal, Feb 2022 11(2), DOI: https://doi.org/10.1530/ETJ-21-0085
Vahabi S, Kharati-Koopaei E, Norouzi M, Maddox J, Humphreys A, Hancock H, Zaman A, Austin D, Right ventricular mechanics in anthracycline chemotherapy: insights into the PROACT PLUS study, European Heart Journal – Cardiovascular Imaging, 2022, vol 23(1). https://doi.org/10.1093/ehjci/jeab289.418
Vahabi S, Kharati-Koopaei E, Norouzi M, Maddox J, Humphreys A, Hancock H, Zaman A, Austin D, Atrial mechanics in anthracycline chemotherapy: insights into a prospective study, European Heart Journal – Cardiovascular Imaging, vol 23(1). https://doi.org/10.1093/ehjci/jeab289.027
Vahabi S, Kharati-Koopaei E, Norouzi M, Maddox J, Humphreys A, Hancock H, Zaman A, Austin D, Anthracycline chemotherapy and its effects on left ventricular mechanics: insights into the PROACT PLUS study, European Heart Journal – Cardiovascular Imaging, Feb 2022, vol 23(1). https://doi.org/10.1093/ehjci/jeab289.026
2020 and prior
The effects of doxorubicin on left and right atrial mechanics in patients with lymphoma, Vahabi S, Kharati-Koopaei E, Stewart M, Hancock H, Norouzi M, Maddox J, Austin D, European Heart Journal, 2020, vol 41(2)
Prevalence, predictors and outcomes of thyroid dysfunction in patients with acute myocardial infarction: the ThyrAMI-1 study, Jabbar A, Ingoe L, Thomas H, Carey P, Junejo S, Addison C, Vernazza J, Austin D, Greenwood J, Zaman A & Razvi S, Journal of Endocrinological Investigation, 2021, 44 p.1209–1218
Effect of Levothyroxine on Left Ventricular Ejection Fraction in Patients With Subclinical Hypothyroidism and Acute Myocardial Infarction: A Randomized Clinical Trial, Avais Jabbar A, Ingoe L, Junejo S, Carey P, Addison C, Thomas H, Parikh J, Austin D, JAMA The Journal of the American Medical Association 2020, 324(3) p.249-258
Rapid Aspirin Desensitization is Safe and Feasible in Patients With Stable and Unstable Coronary Artery Disease: A Single-Center Experience, Jackson M, Callaghan S, Stapleton J, Bolton S, Austin D, et al, Journal of Cardiovascular Pharmacology and Therapeutics, 2019, pp359–364.
Optical Coherence Tomography Evaluation of Coronary Dissection and Intramural Hematoma, Hayat U, Williams PD, Austin D. Optical Coherence Tomography Evaluation of Coronary Dissection and Intramural Hematoma, The Journal of Invasive Cardiology, 2019, 31(1):E6
The impact of diabetes on the prognostic value of left ventricular function following percutaneous coronary intervention: Insights from the British Cardiovascular Intervention Society, Jackson M, Austin D, Kwok CS, et al, Catheter & Cardiovascular Interventions, 2018, 15;92(6):E393-E402.
Radial Versus Femoral Access for Rotational Atherectomy; A UK Observational Study of 8622 Patients, Watt J, Austin D, Mackay D, Nolan J, Oldroyd K, Circulation: Cardiovascular Interventions, 2017,vol.10(12)
27 Use of rotational atherectomy in primary pci for st-elevation myocardial infarction- a single centre 10-year experience, Mahmood M, Qureshi M, Morley R, Austin D et al, Heart, 2017;103:A22-A23
30 Do PRAMI and CVLPRIT represent real-life experiences of culprit-only PPCI? – a single centre observational study, Jackson M, Austin D, Hall J, et al, Heart 2016;102:A13-A14
High-bolus dose tirofiban compared with abciximab in primary percutaneous coronary intervention: a propensity score-matched outcome study, Austin D, Mackay D, Morley R, Christie J. et al, EuroIntervention 2015;10:1187-1194
Patient characteristics associated with self-presentation, treatment delay and survival following primary percutaneous coronary intervention , Austin D, Yan A, Spratt J, Kunadian V, Edwards R, Egred M, Bagnall A, European Heart Journal, Acute Cardiovascular Care, Sept 2014 Vol. 3(3:1) p.214–222
Treatment delay in primary PCI in relation to marital status and distance from acute medical care, Austin D, Yan, Jamieson S, Zaman A, Kunadian V, Bagnall A, European Heart Journal, Aug 2013 Vol.34, p469
Drug-coated balloons in treatment of in-stent restenosis: a meta-analysis of randomised controlled trials, Navarese E, Austin D, Gurbel P, Andreotti F, et al, Clinical Research in Cardiology, 2013,102, p279–287
A critical overview on ticagrelor in acute coronary syndromes, Navarese E, Buffon A, Kozinski M, Obonska K, Rychter M, Kunadian V, Austin D, De Servi S, Sukiennik S, Kubica J, QJM: An International Journal of Medicine, 2013 vol.106(2) p105–115
TCT-463 In-hospital Mortality Following Primary Angioplasty in the Setting of Cardiac Arrest is High and Varies Depending on Patient Location at the Time of Arrest: A UK Registry Database Study, Kunadian V, Austin D, Bland J, et al, Journal of the American College of Cardiology, 2012 vol.60(17) p.B133
Compression of Main Pulmonary Artery by Giant Saphenous Vein Graft Aneurysm, Austin D, Asopa S, Owens A, Hall J, The Annals of Thoracic Surgery, Aug 2011, Vol.92(2)p.742
1 Route of admission in stemi: do patients who present directly to a PCI-capable hospital differ from inter-hospital transfers? Austin D, Adam Z, Shome J, et al, Heart, 2011;97:A5
Drug-eluting stents: a study of appropriateness and variations in practice, Austin D, M.D. thesis submitted to the Faculty of Medicine, Division of Community Based Sciences, University of Glasgow, 2010
Drug-eluting stents: A study of international practice, Austin D, Oldroyd K, Holmes D, Rihal C, Galbraith D, Ghali W, Legrand V, Taeymans Y, McConnachie A, Pell J, American Heart Journal, 2009, Vol. 158 (4) p.576-584
Observational studies of drug-eluting stents – Some are more equal than others, Austin D, Oldroyd K, Pell J, EuroIntervention, 2009, 4:p419-423
Drug-Eluting Stents Versus Bare-Metal Stents for Off-Label Indications, A Propensity Score–Matched Outcome Study Austin D, Oldroyd K, McConnachie A, et al Circulation: Cardiovascular Interventions, 2008;1:45–52
Bare-Metal versus Drug-Eluting Coronary Stents, Austin D, Pell J, Oldroyd K. et al, New England Journal of Medicine, June 2008, 358(23):2516
Hospital and operator variations in drug-eluting stent use: a multi-level analysis of 5967 consecutive patients in Scotland, Austin D, Oldroyd K, McConnachie A. et al, Journal of Public Health, 2008 vol.30(2)p.186–19
Drug-Eluting Stents: A Review of Current Evidence on Clinical Effectiveness and Late Complications, Austin D, Oldroyd K, Pell J, Scottish Medical Journal, Feb 2008, 53(1):16-24
Drug-eluting stents: do the risks really outweigh the benefits?Austin D, Pell JP, Oldroyd KG, Heart 2008;94:127-128.
The rise and fall of drug-eluting stents: Time trend analysis in 13 647 consecutive patients undergoing percutaneous coronary intervention, Austin D, Pell JP, Oldroyd KG, American Heart Journal, 2008 vol.154(5)p.e37
Is There Ageism in Oncology? Austin D, Russell M, Scottish Medical Journal, 2003, vol.48(1)p.17-20
Drug-eluting stents versus bare-metal stents for off-label indications, Austin D, Oldroyd K, McConnachie A, Slack R, Eteiba H, Flapan, A, Jennings K, Northcote R, Pell A, Starkey I, Pell J, Circulation; Cardiovascular Interventions, 2008, vol.1(1)p.45-52